BD Vialon, a unique proprietary biomaterial, has been proven to enhance clinical and economic outcomes.*With the push of a button, the needle instantly retracts reducing the risk of accidental needlestick injuries.*Increases the ease of penetration*Reduces the risks ofinfiltration*Exhibits greater kink resistance*Reduces the risks of phlebitis up to 50%*Reduces IV restarts due to reduced complications*Increases indwelling time*Reduces the total IV therapy costs to use due to longer indwelling times.